Objective Although several assays have been developed to detect SARS-CoV-2 RNA in
clinical specimens, their relative performance is unknown. Methods The concordance between …

Letermovir is an effective antiviral agent for CMV prevention and has demonstrated enhanced
safety, which may allow for extended durations of primary prophylaxis among transplant …

Our transplant recipients require a three-dose mRNA or adenovirus-vector and one dose of
mRNA vaccine to be optimally protected initially; they then need to receive a bivalent booster …

Deceased donor and organ perfusion fluid cultures are obtained in order to inform recipient
antimicrobial management and therefore reduce the risk of donor‐derived bacterial and …

3D-printed alternatives to standard flocked swabs were rapidly developed to provide a
response to the unprecedented and sudden need for an exponentially growing amount of …

Background Primary antifungal prophylaxis with mold-active azoles is used to prevent
invasive fungal infections in patients with high-risk hematological disorders; however, …

Invasive fungal infections are increasingly encountered with the expansion of iatrogenic
immunosuppression, including not only solid organ and hematopoietic stem cell transplant …

Objectives To clarify perceived benefits, barriers and facilitators of Mycobacterium tuberculosis
next-generation sequencing implementation in Madagascar and Canada, towards …

Background Among lung transplant recipients, serial bronchoscopies are performed frequently.
Often, serial galactomannan (GM), 1,3‐β‐d‐glucan (BDG), and Pneumocystis jirovecii (…

Background Chemotherapy has been associated with a theoretical risk of hepatitis C virus (HCV)
reactivation. However, little is known about the amplitude of viral replication and the …